Highlights From AACR IO 2026: Breaching the Tumor Microenvironment Fortress With New CAR T and Chimeras
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
Excitement and emotion ran high Sunday morning as Margaret Foti, PhD, MD (hc), chief executive officer of the American...
The American Association for Cancer Research (AACR) is proud to offer Global Scholar-in-Training Awards (GSITA) to support the career...
As we finally welcome spring, enjoy this hand-picked selection of articles brought to you by the editors of the...
In 2015, NFL running back Brandon Bolden was having an incredible season with the New England Patriots. That year,...
For more than 20 years, the Scientist↔Survivor Program (SSP) has played a vital role in the American Association for...
For the first time since 2019, the American Association for Cancer Research (AACR) Annual Meeting is set to return...
Guest Post by William G. Nelson, MD, PhD Editor-in-Chief, Cancer Today The nationwide shutdown of elective clinical procedures implemented in...
Next-generation genome analysis technologies allow for the sequencing of multiple genes at once to characterize the mutational profile of...
It is an exciting era for drug development in oncology. The many discoveries of new molecular targets, coupled with...
As we move slowly toward longer days and warmer temperatures, we bring you the latest round of highlighted articles...